RML MAINS 2025
Pharmacology
Hard

A child is admitted with frequent seizures and irritability. The doctor prescribes a drug that controls seizures and also has sedative properties. Which drug is most appropriate?

Appeared in: RML MAINS 2025

Explanation

  • Phenobarbitone is a barbiturate that possesses both strong anticonvulsant and sedative properties.
  • Its mechanism involves enhancing the effect of the inhibitory neurotransmitter GABA in the brain, which leads to central nervous system depression, thereby controlling seizures and producing a calming effect.
  • This dual action makes it particularly suitable for a patient who is not only having seizures but is also irritable.
  • While effective, its use has declined due to side effects like sedation and potential cognitive impairment with long-term use (SRC_20229).

Why Other Options Were Wrong

  • Option A: Carbamazepine is a primary antiepileptic drug but does not have the strong sedative properties of phenobarbitone. While it can cause drowsiness, it is not its primary feature.
  • Option C: Phenytoin is a first-line antiepileptic drug that is not a general CNS depressant and produces minimal sedation at therapeutic doses.
  • Option D: Lithium is a mood stabilizer, not an antiepileptic drug. It is used to treat bipolar disorder and has no indication for seizure control.

Related Visual

Visual explanation — Related Visual
Clinical Relevance
  • Nursing practice connection: Prioritize focused assessment, early escalation, and real-time monitoring when managing Pharmacological management of seizures with consideration of drug side effect profiles in acute care settings.
  • When administering phenobarbitone, nurses must prioritize monitoring for excessive sedation and respiratory depression, especially in children and with IV use.
  • It is crucial to educate parents about the importance of adherence and the dangers of abrupt discontinuation, which can lead to status epilepticus.
  • Paradoxical hyperactivity can occur in children taking phenobarbitone, so any unusual changes in behavior should be reported to the prescriber.
How to Approach the Question
  • First, analyze the clinical scenario to identify the patient's needs. The patient is a child with both 'frequent seizures' and 'irritability'.
  • The question asks for the 'most appropriate' drug, which implies you must find the best fit for both conditions.
  • Break down the requirements: the drug must have 1) anticonvulsant action and 2) sedative properties.
  • Evaluate each option against these two requirements.
  • Eliminate Lithium as it is a mood stabilizer, not an antiepileptic.
  • Compare the remaining antiepileptics (Carbamazepine, Phenobarbitone, Phenytoin) based on their sedative effects. Phenytoin and Carbamazepine have minimal sedative properties compared to Phenobarbitone.
Concept Tested & Keywords
  • Concept Tested: Pharmacological management of seizures with consideration of drug side effect profiles.
  • Stem keywords: child, frequent seizures, irritability, sedative properties, antiepileptic
  • Lead-in keywords: most appropriate
  • Clinical cues: [object Object]
  • Negative lead-in flag: false

Question ID

QJxUT_o3M3CLPtm_fwdgWB

Reference Book

E6 Pharmacology KD Tripathi Essentials 9e Part 2 p. 80-82

E6 Pharmacology Nursing Lilley 11e Part 1 p. 240-242

E6 Pharmacology Nurses Shanbhag 3e p. 155-157

Practise the full RML MAINS 2025

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Drugs Acting on Central Nervous System Questions

More RML MAINS 2025 Questions